Consequently, due to the associated tumor risk, early screening for neoplasms is recommended, using abdominal ultrasounds (aimed at identifying renal tumors, particularly Wilms tumor) and serum AFP tests (targeted at detecting liver tumors, especially hepatoblastoma) [2,6,11,20]. This evidence concerns the gene AFP and Nephroblastoma.